Key result
Pyridostigmine yields significant improvement in a POTS patient with genetic variants in acetylcholine processing.
Why the study?
Does pyridostigmine improve symptoms in a patient with POTS and genetic variants in acetylcholine processing?
Does pyridostigmine improve symptoms in a patient with POTS and genetic variants in acetylcholine processing?
Pyridostigmine may provide significant improvement in POTS patients with genetic variants in acetylcholine processing.
May support pyridostigmine trial in select POTS cases; hypothesis-generating case report requiring prospective validation.
To describe genetic variants in acetylcholine processing found in a patient with postural orthostatic tachycardia syndrome (POTS) and positive response to pyridostigmine
No takes yet. Share an insight, caveat, or question.
Stephenson et al. (2026) studied this question. Pyridostigmine provided significant clinical improvement in a patient with postural orthostatic tachycardia syndrome and genetic variants in acetylcholine processing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: